Health-related quality of life in patients with chronic hepatitis B


Zobair M. Younossi, MD, MPH, Center for Liver Diseases, Inova Fairfax Hospital, 3289 Woodburn Road, Suite 375, Annandale, VA 22003, USA.
Tel: +703 208 6651
Fax: +703 208 6655


Although chronic hepatitis C (CH-C) has consistently been shown to impair patients' health-related quality of life (HRQL), the impact of chronic hepatitis B (CH-B) on HRQL has not been fully explored.

Aim: Compare HRQL between patients with CH-B, CH-C, primary biliary cirrhosis (PBC) and healthy controls.

Design: Three HRQL questionnaires [Chronic Liver Disease Questionnaire (CLDQ), Short Form 36 (SF-36) and the Health Utility Index (HUI Mark-2 and Mark-3)] were administered prospectively. Additional clinical and laboratory data and normative data for healthy individuals, were available.

Analysis: Scores were compared using analysis of variance and multiple regression.

Results: One hundred and forty-six patients with CH-B, CH-C and PBC were included [mean age 47.1 years (±11.6), 41% female, 33% cirrhosis]. CH-C and PBC patients scored the lowest on all CLDQ, SF-36 and HUI domains compared with CH-B patients and healthy controls. CH-B patients had scores similar to the healthy population, measured by most CLDQ and SF-36 scales. However, the HUI scores for CH-B patients showed more impairment than population norms. Having CH-B and not having cirrhosis were predictive of utility and HRQL scores in multivariate models.

Conclusions: CH-B patients have better HRQL than CH-C, PBC and population norms. CH-B patients' overall utility scores are lower than population norms.